The global gastrointestinal endoscopy market was valued at $13.40 billion in 2021 and is anticipated to reach $25.75 billion by 2031, witnessing a CAGR of 6.24% during the forecast period 2022-2031.
The market is driven by factors such as the increasing prevalence of gastrointestinal diseases, rising preference for minimally invasive surgeries, growing demand for capsule endoscopy, the shift from reusable endoscopes to disposable endoscopes, and technological advancements in the field of robot-assisted endoscopes and AI-based devices.
Flow Cytometry in Oncology and Immunology Market Analysis and Forecast, 2022-...BIS Research Inc.
The global flow cytometry in oncology and immunology market is anticipated to reach $5,287.4 million by 2032, witnessing a CAGR of 11.39% during the forecast period 2022-2032.
The global liquid biopsy market was estimated to be at $2,508.2 million in 2021, which is expected to grow with a CAGR of 19.83% and reach $19,066.0 million by 2032.
Table of Content - Global Prostate Cancer Testing Market.pdfBIS Research Inc.
The global prostate cancer testing market was valued at $5,246.9 million in 2021, and it is expected to reach $21,306.9 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032.
Pharmaceutical Aseptic Transfer Market Analysis and Forecast, 2022-2031BIS Research Inc.
The global pharmaceutical aseptic transfer market is projected to reach $2,551.5 million by 2031 from $855.2 million in 2021 at a CAGR of 9.61% during the forecast period 2022-2031.
Laboratory Informatics Market Analysis and Forecast, 2022-2032BIS Research Inc.
The global laboratory informatics market is anticipated to reach $12,677.0 million by 2032, witnessing a CAGR of 10.27% during the forecast period 2022-2032.
The Blood and Plasma Components Market size in 2020 was $39.58 billion and is expected to reach $66.47 billion in 2031, growing at a CAGR of 4.90% over the forecast period 2021-2031.
The global CRISPR gene editing market was valued at $1,088.6 million in 2020, and it is expected to reach $18,856.6 million by 2031, registering a CAGR of 29.60% during the forecast period.
Flow Cytometry in Oncology and Immunology Market Analysis and Forecast, 2022-...BIS Research Inc.
The global flow cytometry in oncology and immunology market is anticipated to reach $5,287.4 million by 2032, witnessing a CAGR of 11.39% during the forecast period 2022-2032.
The global liquid biopsy market was estimated to be at $2,508.2 million in 2021, which is expected to grow with a CAGR of 19.83% and reach $19,066.0 million by 2032.
Table of Content - Global Prostate Cancer Testing Market.pdfBIS Research Inc.
The global prostate cancer testing market was valued at $5,246.9 million in 2021, and it is expected to reach $21,306.9 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032.
Pharmaceutical Aseptic Transfer Market Analysis and Forecast, 2022-2031BIS Research Inc.
The global pharmaceutical aseptic transfer market is projected to reach $2,551.5 million by 2031 from $855.2 million in 2021 at a CAGR of 9.61% during the forecast period 2022-2031.
Laboratory Informatics Market Analysis and Forecast, 2022-2032BIS Research Inc.
The global laboratory informatics market is anticipated to reach $12,677.0 million by 2032, witnessing a CAGR of 10.27% during the forecast period 2022-2032.
The Blood and Plasma Components Market size in 2020 was $39.58 billion and is expected to reach $66.47 billion in 2031, growing at a CAGR of 4.90% over the forecast period 2021-2031.
The global CRISPR gene editing market was valued at $1,088.6 million in 2020, and it is expected to reach $18,856.6 million by 2031, registering a CAGR of 29.60% during the forecast period.
The global dental radiography market is expected to reach $3,914.8 million by the end of 2031. The market is expected to grow at a CAGR of 5.17% during the forecast period 2022-2031.
The Canada laparoscopy devices market was valued at $392.1 million in 2021 and is anticipated to reach $865.6 million by 2031, witnessing a CAGR of 7.31% during the forecast period 2022-2031.
The global NGS informatics market is projected to reach $6,715.0 million by 2032. The market is expected to grow at a CAGR of 15.21% during the forecast period 2022-2032.
Global Viral and Non-Viral Vector Manufacturing Market.pdfBIS Research Inc.
The global viral and non-viral vector manufacturing market was valued at $1.50 billion in 2020 and is expected to reach $27.03 billion by 2031, witnessing a CAGR of 18.54% during the forecast period 2021-2031.
Global Viral and Non-Viral Vector Manufacturing MarketBIS Research Inc.
The global viral and non-viral vector manufacturing market was valued at $1.50 billion in 2020 and is expected to reach $27.03 billion by 2031, witnessing a CAGR of 18.54% during the forecast period 2021-2031.
Propane dehydrogenation to propylene market is projected to reach $22,721.2 million by 2031. PDH to propylene market has been in its growth stage.
Read Report Overview: https://bisresearch.com/industry-report/propane-dehydrogenation-propylene-market.html
Carrier Screening Market - A Global and Regional AnalysisBIS Research Inc.
The global carrier screening market is projected to reach $4,479.0 million by 2031, growing from $1,187.4 million in 2020, at a CAGR of 12.67% during the forecast period 2021-2031.
Surface Treatment Chemicals Market Size In 2019 and Growth Insights to 2025 |...Harsh Singla
Chemical surface treatment is a modification of the aluminum surface through chemical processes. This type of surface treatment is used most often as a pre-treatment method for subsequent finishing operations, such as anodizing or powder coating.
According to Bis Research, the global surface treatment chemicals market accounted for $6,187.4 M in 2019 & is expected to be $7,833.5 M by 2025. The market will grow at a CAGR of 6.19% during the forecast period 2020-2025.
To know more about Surface Treatment Chemicals Market and about its market, please follow the link given below:
https://bisresearch.com/industry-report/global-surface-treatment-chemicals-market.html
To get the detailed report with excessive data on the Surface Treatment Chemicals Market please follow the given link:
https://bisresearch.com/requestsample?id=980&type=requestUpdatedVersion
The global biomaterials market was valued at $122.92 billion in 2020 and is expected to reach $725.88 billion by 2031, growing at a CAGR of 17.98% between 2021 and 2031.
The global big data in healthcare market was valued at $32,925.1 million in 2021 and is expected to reach $130,132.1 million by the end of 2031. The market is expected to grow at a CAGR of 13.96% during the forecast period 2022-2031.
The global large tow carbon fiber market is expected to reach $1,960.3 million by 2031, large tow carbon fiber industry growing at a CAGR of 13.43% during Forecast Period 2022-2031.
Read Report Overview: https://bisresearch.com/industry-report/large-tow-carbon-fiber-market.html
AI-Enabled Imaging Solutions Market - A Global Market Report by BIS ResearchBIS Research Inc.
The global AI-enabled medical imaging solutions market was valued at $1,854.5 million in 2022 and is anticipated to reach $18,356.5 million by 2032, witnessing a CAGR of 25.76% during the forecast period 2022-2032. you can get more info to visit this link..
https://bisresearch.com/industry-report/global-ai-enabled-medical-imaging-solutions-market.html
BIS Research - Variable Rate Technology Market | Trends and Forecast AnalysisBIS Research Inc.
The global variable rate technology market is highly consolidated, with a small number of dominant established players and a smaller number of rising start-ups.
Download the Sample Report of Variable Rate Technology Market at: https://bit.ly/3e3NP58
The global axial spondyloarthritis market was estimated to be at $1,873.8 million in 2021, which is expected to grow with a CAGR of 13.44% and reach $7,937.8 million by 2032.
TOC - Global Extensive Stage Small Cell Lung Cancer Market.pdfBIS Research Inc.
Extensive stage small cell lung cancer is extremely aggressive sub-type of small cell lung cancer. Small cell lung itself is a sub-type of lung cancer which accounts for less than 20% cases. The treatment of extensive stage small cell lung cancer has been extremely challenging owing to poor survival rate of the patients.
The prevalence of extensive stage small lung cancer is estimated to increase in five of the seven major markets included in the study.
Bio-LNG Market is anticipated to reach $3,607.2 million by 2032.pdfMohit BISResearch
Bio-LNG Market is anticipated to reach $3,607.2 million by 2032. the high cost of bio-LNG as compared to LNG is anticipated to hinder market growth in the future.
Read Report Overview: https://bisresearch.com/industry-report/bio-lng-market.html
The global precision medicine market is expected to reach $278.61 billion by the end of 2030. The market is projected to grow at a CAGR of 11.13% during the forecast period, 2020-2030.
The global precision medicine market is expected to reach $278.61 billion by the end of 2030. The market is projected to grow at a CAGR of 11.13% during the forecast period, 2020-2030.
Webinar Presentation Syndromic Testing – A New Take on Diagnosing Infectious ...BIS Research Inc.
The document summarizes a webinar on syndromic testing for diagnosing infectious diseases. The webinar featured several speakers who discussed topics like: how syndromic testing can provide faster results and reduce antibiotic use compared to traditional testing; applications of metagenomics next-generation sequencing (mNGS) in clinical diagnostics and its benefits; key trends in the syndromic testing market like high growth rates and the dominance of respiratory disease testing currently. The global syndromic testing market is expected to grow from $1.28 billion in 2022 to $3.25 billion in 2033, driven by factors like rising infectious disease incidence and the need for early diagnosis.
The global sustainable steel market is projected to reach $795.8 billion by 2031 from $327.3 billion in 2021, growing at a CAGR of 8.97% during the forecast period 2022-2031. The growth in the global sustainable steel market is expected to be driven by stringent government regulations, carbon neutrality targets, energy and cost efficiency owing to the use of recycled steel, and a significant increase in steel demand with the scarcity of raw materials and energy.
More Related Content
Similar to Global Gastrointestinal Endoscopy Market
The global dental radiography market is expected to reach $3,914.8 million by the end of 2031. The market is expected to grow at a CAGR of 5.17% during the forecast period 2022-2031.
The Canada laparoscopy devices market was valued at $392.1 million in 2021 and is anticipated to reach $865.6 million by 2031, witnessing a CAGR of 7.31% during the forecast period 2022-2031.
The global NGS informatics market is projected to reach $6,715.0 million by 2032. The market is expected to grow at a CAGR of 15.21% during the forecast period 2022-2032.
Global Viral and Non-Viral Vector Manufacturing Market.pdfBIS Research Inc.
The global viral and non-viral vector manufacturing market was valued at $1.50 billion in 2020 and is expected to reach $27.03 billion by 2031, witnessing a CAGR of 18.54% during the forecast period 2021-2031.
Global Viral and Non-Viral Vector Manufacturing MarketBIS Research Inc.
The global viral and non-viral vector manufacturing market was valued at $1.50 billion in 2020 and is expected to reach $27.03 billion by 2031, witnessing a CAGR of 18.54% during the forecast period 2021-2031.
Propane dehydrogenation to propylene market is projected to reach $22,721.2 million by 2031. PDH to propylene market has been in its growth stage.
Read Report Overview: https://bisresearch.com/industry-report/propane-dehydrogenation-propylene-market.html
Carrier Screening Market - A Global and Regional AnalysisBIS Research Inc.
The global carrier screening market is projected to reach $4,479.0 million by 2031, growing from $1,187.4 million in 2020, at a CAGR of 12.67% during the forecast period 2021-2031.
Surface Treatment Chemicals Market Size In 2019 and Growth Insights to 2025 |...Harsh Singla
Chemical surface treatment is a modification of the aluminum surface through chemical processes. This type of surface treatment is used most often as a pre-treatment method for subsequent finishing operations, such as anodizing or powder coating.
According to Bis Research, the global surface treatment chemicals market accounted for $6,187.4 M in 2019 & is expected to be $7,833.5 M by 2025. The market will grow at a CAGR of 6.19% during the forecast period 2020-2025.
To know more about Surface Treatment Chemicals Market and about its market, please follow the link given below:
https://bisresearch.com/industry-report/global-surface-treatment-chemicals-market.html
To get the detailed report with excessive data on the Surface Treatment Chemicals Market please follow the given link:
https://bisresearch.com/requestsample?id=980&type=requestUpdatedVersion
The global biomaterials market was valued at $122.92 billion in 2020 and is expected to reach $725.88 billion by 2031, growing at a CAGR of 17.98% between 2021 and 2031.
The global big data in healthcare market was valued at $32,925.1 million in 2021 and is expected to reach $130,132.1 million by the end of 2031. The market is expected to grow at a CAGR of 13.96% during the forecast period 2022-2031.
The global large tow carbon fiber market is expected to reach $1,960.3 million by 2031, large tow carbon fiber industry growing at a CAGR of 13.43% during Forecast Period 2022-2031.
Read Report Overview: https://bisresearch.com/industry-report/large-tow-carbon-fiber-market.html
AI-Enabled Imaging Solutions Market - A Global Market Report by BIS ResearchBIS Research Inc.
The global AI-enabled medical imaging solutions market was valued at $1,854.5 million in 2022 and is anticipated to reach $18,356.5 million by 2032, witnessing a CAGR of 25.76% during the forecast period 2022-2032. you can get more info to visit this link..
https://bisresearch.com/industry-report/global-ai-enabled-medical-imaging-solutions-market.html
BIS Research - Variable Rate Technology Market | Trends and Forecast AnalysisBIS Research Inc.
The global variable rate technology market is highly consolidated, with a small number of dominant established players and a smaller number of rising start-ups.
Download the Sample Report of Variable Rate Technology Market at: https://bit.ly/3e3NP58
The global axial spondyloarthritis market was estimated to be at $1,873.8 million in 2021, which is expected to grow with a CAGR of 13.44% and reach $7,937.8 million by 2032.
TOC - Global Extensive Stage Small Cell Lung Cancer Market.pdfBIS Research Inc.
Extensive stage small cell lung cancer is extremely aggressive sub-type of small cell lung cancer. Small cell lung itself is a sub-type of lung cancer which accounts for less than 20% cases. The treatment of extensive stage small cell lung cancer has been extremely challenging owing to poor survival rate of the patients.
The prevalence of extensive stage small lung cancer is estimated to increase in five of the seven major markets included in the study.
Bio-LNG Market is anticipated to reach $3,607.2 million by 2032.pdfMohit BISResearch
Bio-LNG Market is anticipated to reach $3,607.2 million by 2032. the high cost of bio-LNG as compared to LNG is anticipated to hinder market growth in the future.
Read Report Overview: https://bisresearch.com/industry-report/bio-lng-market.html
The global precision medicine market is expected to reach $278.61 billion by the end of 2030. The market is projected to grow at a CAGR of 11.13% during the forecast period, 2020-2030.
The global precision medicine market is expected to reach $278.61 billion by the end of 2030. The market is projected to grow at a CAGR of 11.13% during the forecast period, 2020-2030.
Similar to Global Gastrointestinal Endoscopy Market (20)
Webinar Presentation Syndromic Testing – A New Take on Diagnosing Infectious ...BIS Research Inc.
The document summarizes a webinar on syndromic testing for diagnosing infectious diseases. The webinar featured several speakers who discussed topics like: how syndromic testing can provide faster results and reduce antibiotic use compared to traditional testing; applications of metagenomics next-generation sequencing (mNGS) in clinical diagnostics and its benefits; key trends in the syndromic testing market like high growth rates and the dominance of respiratory disease testing currently. The global syndromic testing market is expected to grow from $1.28 billion in 2022 to $3.25 billion in 2033, driven by factors like rising infectious disease incidence and the need for early diagnosis.
The global sustainable steel market is projected to reach $795.8 billion by 2031 from $327.3 billion in 2021, growing at a CAGR of 8.97% during the forecast period 2022-2031. The growth in the global sustainable steel market is expected to be driven by stringent government regulations, carbon neutrality targets, energy and cost efficiency owing to the use of recycled steel, and a significant increase in steel demand with the scarcity of raw materials and energy.
Cybersecurity in Automotive Connected Vehicles and Growing Security Vulnerabi...BIS Research Inc.
• Agenda:
o To evaluate various security vulnerabilities in connected vehicles.
o To analyze the initiatives taken and regulations implemented to address security vulnerabilities.
o To analyze the various types of cybersecurity solutions being developed or offered for the security of connected vehicles.
o To evaluate the major players in the ecosystem.
Report Preview is available at: https://bisresearch.com/industry-report/global-automotive-cybersecurity-market.html
BIS Research conducted a webinar on Carbon Neutral Data Center PracticesBIS Research Inc.
Agenda:
To evaluate various emerging trends in Data center industry.
To analyze the initiatives taken and regulations implemented to increase sustainable practices.
To analyze the various types of technologies currently deployed.
To evaluate the major players in the ecosystem.
Speaker Profiles:
Name: JD Enright, Sr.
Designation: Chief Operating Officer
Company: TMGcore Inc.
Experienced and dedicated business professional with 29 years working with DOD, Multinational Private and Public sector organizations. Primary focus on developing and executing Strategic Step-Up Growth initiatives in Emerging Markets, and Technologies. Specialized leadership in developing improved business operations to include Financial and Operational efficiencies. Implementation of next generation HPC Platforms, Global Blockchain Development Strategies, Biotechnology, Viral Cell and Gene Therapies and Market Intelligence Assimilation for public applications.
Webinar by BIS Research on Precision Oncology BiomarkersBIS Research Inc.
Precision oncology biomarkers are essential tools for tailoring cancer treatment to individual patients, as they provide insights into tumor biology and guide the selection of targeted therapies.
BIS conducted a deep intelligence webinar on the state-of-the-art technologies and emerging strategies used through the precision oncology biomarkers.
Direct-to-Customer Wellness | A Webinar on the Growing Need for Personalized ...BIS Research Inc.
Direct-to-consumer (DTC) wellness testing industry witnessed a strong emphasis on consumer health and wellness, instigating industry stakeholders to discover new revenue streams.
As a leading market intelligence firm, BIS Research strives to stay on top of the latest emerging trends in the healthcare sector, among several other industry verticals. In the bid to do the same, BIS is conducting a deep intelligence webinar on the increasing focus of DTC wellness programs in the healthcare sector.
Read Related Reports Overview at:
https://bisresearch.com/industry-report/global-direct-to-consumer-genetic-testing-market.html
https://bisresearch.com/industry-report/us-dtc-wellness-testing-market.html
Emerging Battery Chemistries | Reimagining EVs Beyond Conventional Li-Ion Bat...BIS Research Inc.
The efficiency of the battery system in any electric vehicle (EV) determines its cost and vehicle performance. Challenges, such as range anxiety and charging time, have been a hindrance to increasing EV sales.
As a leading market intelligence firm, BIS Research strives to stay on top of the latest emerging technologies in the mobility sector, among several other industry verticals.
In the bid to do the same, BIS is conducting a deep intelligence webinar on the current paradigm shift happening for battery technologies in electric vehicles.
Here are all the details:
Webinar Topic: Emerging Battery Chemistries | Reimagining EVs Beyond Conventional Li-Ion Batteries
Webinar on AI in Medical Diagnosis with Emerging TechnologiesBIS Research Inc.
Artificial Intelligence (AI) is a rapidly growing field that has the potential to revolutionize the way medical diagnosis is performed. AI systems use advanced algorithms to analyze large amounts of data, such as medical images, patient histories, and lab results, to identify patterns and make predictions about patient outcomes.
In medical diagnosis, AI can be used in a variety of ways, including medical imaging, disease diagnosis, personalized treatment planning, and early disease detection. By leveraging the power of AI, healthcare providers can make faster and more accurate diagnoses, resulting in better patient outcomes.
Agenda:
The main agenda of this webinar is to understand and explore the following:
• Policy implications related to AI and digital transformation in healthcare.
• Initiatives taken and regulations implemented to address cybersecurity concerns.
• Major factors driving and hindering the growth of AI in medical devices diagnosis.
• Major players in the ecosystem
The global demand for achieving the net zero emission target by 2050 has pushed governments all over to adapt and adopt advanced carbon removal technologies to go carbon negative.
It is, indeed, an important topic of discussion, because a carbon free environment is the need of the hour to save our planet. And, therefore, BIS Research is glad to announce its upcoming webinar on this particular subject.
Agenda:
The main agenda of this webinar is to understand and explore the following:
• Primary sources of carbon emissions and associated environmental issues
• Carbon dioxide removal – key technology and adoption scenario
• Carbon dioxide removal (CDR): trends and key market developments
• Carbon dioxide removal as a credible solution
• Conclusion and future outlook
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy DevelopmentBIS Research Inc.
Agenda of the Webinar:
Cell and Gene Therapy Biomanufacturing Market: Trends and Key Developments
Awaited Technologies in the Cell and Gene Therapy Development
Regulatory Scenario – GMP/cGMP Guidelines
Biomanufacturing 4.0 - Adoption Scenario
Conclusion and Future Outlook
Sub-Orbital Testing Services Market Future Growth and Business Opportunities ...BIS Research Inc.
Sub-orbital platforms are increasing access to the near space-like environment for end users such as government agencies, research institutions, and commercial players.
The competitive landscape of the sub-orbital testing services market consists of several organic and inorganic strategies followed by the key players to increase their market share.
The space industry is continuously innovating and developing advanced technologies with the objective of enhancing space capabilities. The industry is gearing up to develop vehicles that entail a major feature, i.e., reusability.
Request for the sample of the report at: https://bisresearch.com/requestsample?id=1442&type=download
TOC - Global Military Robotic and Autonomous Systems (RAS) Market.pdfBIS Research Inc.
The robotic and autonomous system (RAS) is a multidisciplinary scientific and technological domain for implementing complex systems with cognitive capabilities.
RAS in military is being rigorously introduced and used in combat training. This has boosted the capabilities of armed units and subunits. The advent of artificial intelligence (AI) and its integration with military RAS has the potential to change future warfare.
Growing demand to increase warfighter lethality and remove soldiers from dangerous situations is propelling the global military RAS market.
Request for the sample of the report at: https://bisresearch.com/requestsample?id=1442&type=download
UAV Propulsion System Market Analysis, Statistics, Regional, and Forecast to ...BIS Research Inc.
UAV propulsion system manufacturers have also been inclined to counter the environment and other government regulations by developing sustainable propulsion, i.e., steps toward fossil-free aviation fuels and ion propulsion are a few of such significant innovations.
UAVs can be powered by a variety of different types of engines, including piston engines, turbine engines, Wankel engines, and electric and solar-powered engines.
The global UAV propulsion system market has witnessed a high growth rate in the last five to six years owing to its widespread applications across various industries, which were further bolstered by the COVID-19 pandemic.
Publication of BIS Research on UAV Propulsion System market has some great insights for UAV Propulsion Systems. Get free sample here: https://bisresearch.com/requestsample?id=1443&type=download
Fleet Management Market Trends, Key Players, Industry Analysis and Forecast 2...BIS Research Inc.
A fleet management system, which includes hardware, software and service, has the ability to make decisions for fleet managers and fleet businesses easily.
The ongoing research and development activities in this market are experiencing product launches of fleet management system for fleet owners, fleet managers, or businesses that utilize fleet management on a daily basis.
BIS Research has a new publication on Fleet Management, view free sample here : https://bisresearch.com/requestsample?id=1444&type=download
Agenda:
The main agenda of this webinar is to understand and explore the following:
• LoRaWAN adoption in agricultural applications as well as understanding the trends and key market developments.
• The significance of LoRaWAN in the field of IoT
• A comparative analysis between LoRaWAN and other IoT networks in terms of technology and capabilities.
• The impact of LoRaWAN on the operations of the agriculture industry and common use cases.
• The impact of the implementation of LoRaWAN technology on stakeholders in the agriculture ecosystem.
• The potential challenges that LoRaWAN might face in the future.
• The competitiveness of the market for LoRaWAN technology.
Augmented Reality in Agriculture Analysis and Statistics from 2022-2027BIS Research Inc.
AR depicts superimposing visual, audio, or other sensory data onto the physical world to improve one's experience. It is one of the most popular technological trends in today’s times. AR images can be displayed on a variety of devices, including eyeglasses and goggles, headsets, and heads-up displays such as helmet visors. As more smartphones, tablets, and other handheld devices that support AR are becoming available globally, the most popular way to use AR is on these devices in a variety of apps and games.
Although AR is used to visually communicate information, it is the integration of AR with other technologies that make it possible to adapt to precision farming and visual-based operations. Hence, farmers can utilize AR in combination with other technologies such as artificial intelligence (AI), big data, and the Internet of Things (IoT) to manage the rising food demand.
Get Augmented Reality in Agriculture report overview at: https://bisresearch.com/industry-report/ar-agriculture-market.html
Smart Harvest Market Generated Opportunities, Future Scope 2022-2027BIS Research Inc.
The growth in the global smart harvest market is expected to be driven by increasing smart farming practices among farmers, labor shortage, and growing government support for promoting the use of smart tech in the agriculture industry. Supported by government policies and technological developments, farmers and growers across the globe are expected to increase the implementation of smart harvest technologies. Moreover, the smart harvest market is witnessing several upcoming trends and opportunities, further propelling growth in the industry.
Get the PDF document on the technical aspects of Smart Harvest Market at: https://bisresearch.com/requestsample?id=1386&type=download
Precision Pest Management Market Leading Players, Development and Demand Fore...BIS Research Inc.
While farmers are losing crops due to pests, they have pressure to increase food production to feed the growing world population.
Precision pest management (PPM) is very important to avoid destruction caused by pests and to increase productivity. PPM helps to detect pests early with the help of crop monitoring so they can be controlled early to avoid further losses. The availability of advanced technologies and equipment has made agriculture automation more prevalent in developed countries.
To know more about the in-depth insights on precision pest management market, get PDF document: https://bisresearch.com/requestsample?id=1404&type=download
Agriculture Drones and Robots Market Growth Opportunity, Trends, Demand Analy...BIS Research Inc.
Agriculture drones and robots offer multiple benefits over conventional farming equipment, which is another factor driving the demand for these products in the agriculture industry. The adoption of agriculture drones and robots in commercial farms offers huge cost-saving opportunities.
Request for the Sample of the Report at: https://bisresearch.com/requestsample?id=1425&type=download
Next-Generation Automotive Lighting Industry to See Significant Growth During...BIS Research Inc.
Since the inception of automotive vehicles amongst the masses, automotive lighting has witnessed significant growth owing to the growing safety apprehensions revolving around vehicles.
The rapid technical progress in the automotive lighting field shows that basic light sources based on incandescent and gas-release bulbs have shifted to modern-day technologies such as light-emitting diodes (LEDs), laser technology, and organic light-emitting diodes (OLEDs).
Get the Sample of the Report containing the information on various technical aspects at: https://bisresearch.com/requestsample?id=1435&type=download
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...rightmanforbloodline
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
Trauma Outpatient Center is a comprehensive facility dedicated to addressing mental health challenges and providing medication-assisted treatment. We offer a diverse range of services aimed at assisting individuals in overcoming addiction, mental health disorders, and related obstacles. Our team consists of seasoned professionals who are both experienced and compassionate, committed to delivering the highest standard of care to our clients. By utilizing evidence-based treatment methods, we strive to help our clients achieve their goals and lead healthier, more fulfilling lives.
Our mission is to provide a safe and supportive environment where our clients can receive the highest quality of care. We are dedicated to assisting our clients in reaching their objectives and improving their overall well-being. We prioritize our clients' needs and individualize treatment plans to ensure they receive tailored care. Our approach is rooted in evidence-based practices proven effective in treating addiction and mental health disorders.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
Gemma Wean- Nutritional solution for Artemiasmuskaan0008
GEMMA Wean is a high end larval co-feeding and weaning diet aimed at Artemia optimisation and is fortified with a high level of proteins and phospholipids. GEMMA Wean provides the early weaned juveniles with dedicated fish nutrition and is an ideal follow on from GEMMA Micro or Artemia.
GEMMA Wean has an optimised nutritional balance and physical quality so that it flows more freely and spreads readily on the water surface. The balance of phospholipid classes to- gether with the production technology based on a low temperature extrusion process improve the physical aspect of the pellets while still retaining the high phospholipid content.
GEMMA Wean is available in 0.1mm, 0.2mm and 0.3mm. There is also a 0.5mm micro-pellet, GEMMA Wean Diamond, which covers the early nursery stage from post-weaning to pre-growing.
KEY Points of Leicester travel clinic In London doc.docxNX Healthcare
In order to protect visitors' safety and wellbeing, Travel Clinic Leicester offers a wide range of travel-related health treatments, including individualized counseling and vaccines. Our team of medical experts specializes in getting people ready for international travel, with a particular emphasis on vaccines and health consultations to prevent travel-related illnesses. We provide a range of travel-related services, such as health concerns unique to a trip, prevention of malaria, and travel-related medical supplies. Our clinic is dedicated to providing top-notch care, keeping abreast of the most recent recommendations for vaccinations and travel health precautions. The goal of Travel Clinic Leicester is to keep you safe and well-rested no matter what kind of travel you choose—business, pleasure, or adventure.
Can Allopathy and Homeopathy Be Used Together in India.pdfDharma Homoeopathy
This article explores the potential for combining allopathy and homeopathy in India, examining the benefits, challenges, and the emerging field of integrative medicine.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
This particular slides consist of- what is hypotension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is the summary of hypotension:
Hypotension, or low blood pressure, is when the pressure of blood circulating in the body is lower than normal or expected. It's only a problem if it negatively impacts the body and causes symptoms. Normal blood pressure is usually between 90/60 mmHg and 120/80 mmHg, but pressures below 90/60 are generally considered hypotensive.
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Global Gastrointestinal Endoscopy Market
1. 1
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
Focus on Type, End User, and Region
Analysis and Forecast: 2022-2031
August 2022
Gastrointestinal
Endoscopy
Market -
A Global and
Regional Analysis
Table of Content
3. 3
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
Table of Content
Executive Summary..........................................................................28
Scope of the Study ...........................................................................36
Research Methodology.....................................................................39
1. Markets .....................................................................................45
1.1 Global Market Outlook ....................................................................................46
1.1.1 Product Definition .......................................................................................46
1.1.2 Inclusion and Exclusion Criteria................................................................46
1.1.3 Key Findings................................................................................................47
1.1.4 Market Growth Scenario .............................................................................47
1.1.4.1 Realistic Growth Scenario ................................................................................. 47
1.1.4.2 Optimistic Growth Scenario ............................................................................... 48
1.1.4.3 Pessimistic/Conservative Growth Scenario ....................................................... 49
1.2 Industry Outlook..............................................................................................50
1.2.1 Key Trends...................................................................................................50
1.2.2 Opportunity Assessment............................................................................51
1.2.3 Product Benchmarking...............................................................................53
1.2.4 Comparative Analysis.................................................................................58
1.2.4.1 Conventional Surgery vs. Robot-assisted Surgery ............................................ 58
1.2.4.1.1 Degree of Precision ................................................................................................. 59
1.2.4.1.2 Tactile Sensation ..................................................................................................... 60
1.2.4.1.3 Cost Analysis ........................................................................................................... 61
1.2.4.1.4 Length of Stay.......................................................................................................... 61
1.2.4.2 Disposable Endoscope vs. Reusable Endoscope ............................................. 62
1.2.4.2.1 Infection Control....................................................................................................... 63
1.2.4.2.2 Cost Analysis ........................................................................................................... 65
1.2.4.2.3 Other Parameters .................................................................................................... 65
1.2.5 Patent Analysis............................................................................................66
1.2.6 Clinical Trials ...............................................................................................66
4. 4
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
1.3 Impact of COVID-19 on Global Gastrointestinal Endoscopy Market...........67
1.3.1 Pre-COVID-19...............................................................................................68
1.3.1.1 Procedural Volumes .......................................................................................... 68
1.3.1.2 Business Opportunities...................................................................................... 68
1.3.2 During COVID-19 .........................................................................................68
1.3.2.1 Impact of COVID-19 .......................................................................................... 68
1.3.2.2 Regional Impact of COVID-19 ........................................................................... 69
1.3.2.3 Procedure Volume............................................................................................. 70
1.3.2.4 Opportunities ..................................................................................................... 70
1.3.3 Future Impact of COVID-19.........................................................................71
1.3.3.1 Impact on Demand and Supply ......................................................................... 71
1.3.3.2 Procedural Volumes .......................................................................................... 71
1.3.3.3 Competitive Landscape ..................................................................................... 71
1.4 Business Dynamics.........................................................................................72
1.4.1 Impact Analysis ...........................................................................................72
1.4.2 Business Drivers .........................................................................................73
1.4.2.1 Increasing Prevalence of Chronic Gastrointestinal Diseases ............................ 73
1.4.2.2 Upsurge in Adoption of Disposable Gastrointestinal Endoscopes..................... 75
1.4.2.3 Rising Inclination toward Minimally Invasive Procedures .................................. 76
1.4.2.4 Shift toward Wireless Capsule Endoscopy ........................................................ 77
1.4.3 Business Challenges ..................................................................................77
1.4.3.1 Dearth of Skilled Healthcare Professionals ....................................................... 77
1.4.3.2 Lack of Reimbursement Frameworks ................................................................ 78
1.4.4 Business Opportunities..............................................................................79
1.4.4.1 Leveraging Synergies to Diversify Business Portfolio ....................................... 79
1.4.4.2 Technological Advancements in Gastrointestinal Endoscopy Devices ............. 79
2. Global Gastrointestinal Endoscopy Market (by Type) .................80
2.1 Overview...........................................................................................................81
2.2 Opportunity Assessment ................................................................................82
2.3 Gastrointestinal Endotherapy.........................................................................82
5. 5
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
2.3.1 ERCP Devices..............................................................................................83
2.3.2 Gastrointestinal Stents ...............................................................................84
2.3.2.1 Esophageal Stents............................................................................................. 85
2.3.2.2 Biliary Stents...................................................................................................... 86
2.3.2.3 Pancreatic Stents............................................................................................... 87
2.3.3 Balloon Dilators...........................................................................................88
2.3.4 Ultrasound Endoscopes .............................................................................89
2.3.5 Biopsy Devices............................................................................................90
2.3.5.1 Biopsy Forceps.................................................................................................. 91
2.3.5.2 Polypectomy Snares.......................................................................................... 92
2.3.5.3 Other Biopsy Devices ........................................................................................ 93
2.3.6 Hemostasis Devices....................................................................................94
2.3.7 Retrieval Devices.........................................................................................94
2.3.8 Others...........................................................................................................95
2.4 Gastrointestinal Endoscopes and Endoscopic Systems.............................96
2.4.1 Gastrointestinal Videoscopes ....................................................................97
2.4.1.1 Gastroscopes..................................................................................................... 98
2.4.1.2 Colonoscopes.................................................................................................... 99
2.4.1.3 Duodenoscopes............................................................................................... 100
2.4.1.4 Sigmoidoscopes .............................................................................................. 101
2.4.1.5 Enteroscopes................................................................................................... 102
2.4.1.6 Anoscopes....................................................................................................... 103
2.4.2 Visualization Systems...............................................................................104
2.4.3 Capsule Endoscopes ................................................................................105
3. Global Gastrointestinal Endoscopy Market (by End User).........107
3.1 Overview.........................................................................................................108
3.2 Opportunity Assessment ..............................................................................108
3.3 Hospitals.........................................................................................................109
3.4 Ambulatory Surgery Centers........................................................................110
3.5 Others .............................................................................................................111
6. 6
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
4. Region .....................................................................................112
4.1 North America................................................................................................115
4.1.1 Regulatory Framework..............................................................................115
4.1.2 Key Findings and Opportunity Assessment ...........................................116
4.1.3 Market Dynamics.......................................................................................117
4.1.3.1 Impact Analysis................................................................................................ 118
4.1.4 Sizing and Forecast Analysis...................................................................118
4.1.4.1 North America Gastrointestinal Endoscopy Market (by End User).................. 119
4.1.4.2 North America Gastrointestinal Endoscopy Market (by Type)......................... 120
4.1.4.2.1 North America Gastrointestinal Endoscopy Market (by Gastrointestinal
Endoscopes and Endoscopic Systems)................................................................ 120
4.1.4.2.1.1 North America Gastrointestinal Endoscopy Market (by Gastrointestinal
Videoscopes)......................................................................................................... 121
4.1.4.2.2 North America Gastrointestinal Endoscopy Market (by Gastrointestinal
Endotherapy)......................................................................................................... 122
4.1.4.2.2.1 North America Gastrointestinal Endoscopy Market (by Gastrointestinal
Stents)................................................................................................................... 122
4.1.4.2.2.2 North America Gastrointestinal Endoscopy Market (by Biopsy Devices)....... 123
4.1.4.3 North America Gastrointestinal Endoscopy Market (by Country) .................... 123
4.1.4.3.1 U.S. ........................................................................................................................ 123
4.1.4.3.1.1 U.S. Gastrointestinal Endoscopy Market (by End User) ................................ 125
4.1.4.3.1.2 U.S. Gastrointestinal Endoscopy Market (by Type) ....................................... 125
4.1.4.3.2 Canada................................................................................................................... 126
4.1.4.3.2.1 Canada Gastrointestinal Endoscopy Market (by End User)........................... 128
4.1.4.3.2.2 Canada Gastrointestinal Endoscopy Market (by Type).................................. 128
4.2 Europe ............................................................................................................131
4.2.1 Regulatory Framework..............................................................................131
4.2.2 Key Findings and Opportunity Assessment ...........................................131
4.2.3 Market Dynamics.......................................................................................132
4.2.3.1 Impact Analysis................................................................................................ 134
4.2.4 Sizing and Forecast Analysis...................................................................135
7. 7
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
4.2.4.1 Europe Gastrointestinal Endoscopy Market (by End User) ............................. 136
4.2.4.2 Europe Gastrointestinal Endoscopy Market (by Type) .................................... 136
4.2.4.2.1 Europe Gastrointestinal Endoscopy Market (by Gastrointestinal Endoscopes
and Endoscopic Systems)..................................................................................... 137
4.2.4.2.1.1 Europe Gastrointestinal Endoscopy Market (by Gastrointestinal
Videoscopes)......................................................................................................... 138
4.2.4.2.2 Europe Gastrointestinal Endoscopy Market (by Gastrointestinal Endotherapy)
............................................................................................................................... 138
4.2.4.2.2.1 Europe Endoscopy Market (by Gastrointestinal Stents)................................. 139
4.2.4.2.2.2 Europe Gastrointestinal Endoscopy Market (by Biopsy Devices) .................. 140
4.2.4.3 Europe Gastrointestinal Endoscopy Market (by Country)................................ 140
4.2.4.3.1 Germany ................................................................................................................ 140
4.2.4.3.1.1 Germany Gastrointestinal Endoscopy Market (by End User)......................... 141
4.2.4.3.1.2 Germany Gastrointestinal Endoscopy Market (by Type)................................ 142
4.2.4.3.2 U.K. ........................................................................................................................ 142
4.2.4.3.2.1 U.K. Gastrointestinal Endoscopy Market (by End User) ................................ 144
4.2.4.3.2.2 U.K. Gastrointestinal Endoscopy Market (by Type) ....................................... 144
4.2.4.3.3 France.................................................................................................................... 145
4.2.4.3.3.1 France Gastrointestinal Endoscopy Market (by End User) ............................ 146
4.2.4.3.3.2 France Gastrointestinal Endoscopy Market (by Type) ................................... 147
4.2.4.3.4 Italy......................................................................................................................... 147
4.2.4.3.4.1 Italy Gastrointestinal Endoscopy Market (by End User)................................. 149
4.2.4.3.4.2 Italy Gastrointestinal Endoscopy Market (by Type)........................................ 150
4.2.4.3.5 Spain...................................................................................................................... 150
4.2.4.3.5.1 Spain Gastrointestinal Endoscopy Market (by End User) .............................. 152
4.2.4.3.5.2 Spain Gastrointestinal Endoscopy Market (by Type) ..................................... 153
4.2.4.3.6 Rest-of-Europe....................................................................................................... 153
4.2.4.3.6.1 Rest-of -Europe Gastrointestinal Endoscopy Market (by End User).............. 154
4.2.4.3.6.2 Rest-of-Europe Gastrointestinal Endoscopy Market (by Type)...................... 155
4.3 Asia-Pacific ....................................................................................................157
8. 8
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
4.3.1 Regulatory Framework..............................................................................157
4.3.2 Key Findings and Opportunity Assessment ...........................................158
4.3.3 Market Dynamics.......................................................................................159
4.3.3.1 Impact Analysis................................................................................................ 160
4.3.4 Sizing and Forecast Analysis...................................................................161
4.3.4.1 Asia-Pacific Gastrointestinal Endoscopy Market (by End User) ...................... 162
4.3.4.2 Asia-Pacific Gastrointestinal Endoscopy Market (by Type) ............................. 162
4.3.4.2.1 Asia-Pacific Gastrointestinal Endoscopy Market (by Gastrointestinal
Endoscopes and Endoscopic Systems)................................................................ 163
4.3.4.2.1.1 Asia-Pacific Gastrointestinal Endoscopy Market (by Gastrointestinal
Videoscopes)......................................................................................................... 164
4.3.4.2.2 Asia-Pacific Gastrointestinal Endoscopy Market (by Gastrointestinal
Endotherapy)......................................................................................................... 164
4.3.4.2.2.1 Asia-Pacific Gastrointestinal Endoscopy Market (by Gastrointestinal
Stents)................................................................................................................... 165
4.3.4.2.2.2 Asia-Pacific Gastrointestinal Endoscopy Market (by Biopsy Devices)........... 165
4.3.4.3 Asia-Pacific Gastrointestinal Endoscopy Market (by Country) ........................ 166
4.3.4.3.1 Japan ..................................................................................................................... 166
4.3.4.3.1.1 Japan Gastrointestinal Endoscopy Market (by End User).............................. 167
4.3.4.3.1.2 Japan Gastrointestinal Endoscopy Market (by Type)..................................... 168
4.3.4.3.2 China...................................................................................................................... 168
4.3.4.3.2.1 China Gastrointestinal Endoscopy Market (by End User).............................. 170
4.3.4.3.2.2 China Gastrointestinal Endoscopy Market (by Type)..................................... 171
4.3.4.3.3 South Korea ........................................................................................................... 171
4.3.4.3.3.1 South Korea Gastrointestinal Endoscopy Market (by End User) ................... 173
4.3.4.3.3.2 South Korea Gastrointestinal Endoscopy Market (by Type) .......................... 173
4.3.4.3.4 India ....................................................................................................................... 174
4.3.4.3.4.1 India Gastrointestinal Endoscopy Market (by End User)................................ 175
4.3.4.3.4.2 India Gastrointestinal Endoscopy Market (by Type)....................................... 176
4.3.4.3.5 Australia and New Zealand.................................................................................... 176
9. 9
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
4.3.4.3.5.1 Australia and New Zealand Gastrointestinal Endoscopy Market (by End
User)...................................................................................................................... 178
4.3.4.3.5.2 Australia and New Zealand Gastrointestinal Endoscopy Market (by Type)
........................................................................................................................ 178
4.3.4.3.6 Rest-of-Asia-Pacific ............................................................................................... 179
4.3.4.3.6.1 Rest-of-Asia-Pacific Gastrointestinal Endoscopy Market (by End User)........ 180
4.3.4.3.6.2 Rest-of-Asia-Pacific Gastrointestinal Endoscopy Market (by Type)............... 180
4.4 Latin America.................................................................................................183
4.4.1 Regulatory Framework..............................................................................183
4.4.2 Key Findings and Opportunity Assessment ...........................................183
4.4.3 Market Dynamics.......................................................................................184
4.4.3.1 Impact Analysis................................................................................................ 185
4.4.4 Sizing and Forecast Analysis...................................................................186
4.4.4.1 Latin America Gastrointestinal Endoscopy Market (by End User)................... 187
4.4.4.2 Latin America Gastrointestinal Endoscopy Market (by Type).......................... 187
4.4.4.2.1 Latin America Gastrointestinal Endoscopy Market (by Gastrointestinal
Endoscopes and Endoscopic Systems)................................................................ 188
4.4.4.2.1.1 Latin America Gastrointestinal Endoscopy Market (by Gastrointestinal
Videoscopes)......................................................................................................... 189
4.4.4.2.2 Latin America Gastrointestinal Endoscopy Market (by Gastrointestinal
Endotherapy)......................................................................................................... 189
4.4.4.2.2.1 Latin America Gastrointestinal Endoscopy Market (by Gastrointestinal
Stents)................................................................................................................... 190
4.4.4.2.2.2 Latin America Gastrointestinal Endoscopy Market (by Biopsy Devices)........ 190
4.4.4.3 Latin America Gastrointestinal Endoscopy Market (by Country) ..................... 191
4.4.4.3.1 Mexico.................................................................................................................... 191
4.4.4.3.1.1 Mexico Gastrointestinal Endoscopy Market (by End User)............................ 192
4.4.4.3.1.2 Mexico Gastrointestinal Endoscopy Market (by Type)................................... 193
4.4.4.3.2 Brazil ...................................................................................................................... 193
4.4.4.3.2.1 Brazil Gastrointestinal Endoscopy Market (by End User) .............................. 194
4.4.4.3.2.2 Brazil Gastrointestinal Endoscopy Market (by Type) ..................................... 195
10. 10
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
4.4.4.3.3 Argentina................................................................................................................ 195
4.4.4.3.3.1 Argentina Gastrointestinal Endoscopy Market (by End User)........................ 196
4.4.4.3.3.2 Argentina Gastrointestinal Endoscopy Market (by Type)............................... 197
4.4.4.3.4 Rest-of-Latin America ............................................................................................ 197
4.4.4.3.4.1 Rest-of-Latin America Gastrointestinal Endoscopy Market (by End User)
........................................................................................................................ 198
4.4.4.3.4.2 Rest-of-Latin America Gastrointestinal Endoscopy Market (by Type)............ 199
4.5 Middle East and Africa ..................................................................................201
4.5.1 Regulatory Framework..............................................................................201
4.5.2 Key Findings and Opportunity Assessment ...........................................201
4.5.3 Market Dynamics.......................................................................................202
4.5.3.1 Impact Analysis................................................................................................ 203
4.5.4 Sizing and Forecast Analysis...................................................................203
4.5.4.1 Middle East and Africa Gastrointestinal Endoscopy Market (by End User)..... 204
4.5.4.2 Middle East and Africa Gastrointestinal Endoscopy Market (by Type)............ 205
4.5.4.2.1 Middle East and Africa Gastrointestinal Endoscopy Market (by
Gastrointestinal Endoscopes and Endoscopic Systems) ..................................... 205
4.5.4.2.1.1 Middle East and Africa Gastrointestinal Endoscopy Market (by
Gastrointestinal Videoscopes) .............................................................................. 206
4.5.4.2.2 Middle East and Africa Gastrointestinal Endoscopy Market (by
Gastrointestinal Endotherapy)............................................................................... 207
4.5.4.2.2.1 Middle East and Africa Gastrointestinal Endoscopy Market (by
Gastrointestinal Stents)......................................................................................... 207
4.5.4.2.2.2 Middle East and Africa Gastrointestinal Endoscopy Market (by Biopsy
Devices) ................................................................................................................ 208
4.5.4.3 Middle East and Africa Gastrointestinal Endoscopy Market (by Country) ....... 208
4.5.4.3.1 K.S.A...................................................................................................................... 208
4.5.4.3.1.1 K.S.A. Gastrointestinal Endoscopy Market (by End User) ............................. 210
4.5.4.3.1.2 K.S.A. Gastrointestinal Endoscopy Market (by Type) .................................... 210
4.5.4.3.2 U.A.E...................................................................................................................... 211
4.5.4.3.2.1 U.A.E. Gastrointestinal Endoscopy Market (by End User)............................. 212
11. 11
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
4.5.4.3.2.2 U.A.E. Gastrointestinal Endoscopy Market (by Type).................................... 213
4.5.4.3.3 Rest-of-Middle East and Africa .............................................................................. 213
4.5.4.3.3.1 Rest-of-Middle east and Africa Gastrointestinal Endoscopy Market (by
End User) .............................................................................................................. 215
4.5.4.3.3.2 Rest-of-Middle East and Africa Gastrointestinal Endoscopy Market (by
Type) ..................................................................................................................... 216
5. Markets - Competitive Benchmarking and Company Profiles....217
5.1 Competitive Benchmarking ..........................................................................218
5.1.1 Competitive Landscape ............................................................................218
5.1.1.1 Key Strategies and Developments .................................................................. 218
5.1.1.2 Regulatory and Legal Activities ....................................................................... 219
5.1.1.3 Funding Activities............................................................................................. 219
5.1.1.4 New Offerings.................................................................................................. 220
5.1.1.5 Mergers and Acquisitions ................................................................................ 221
5.1.1.6 Partnerships, Collaborations, and Business Expansions ................................ 221
5.2 Market Share Analysis ..................................................................................223
5.3 Company Profiles ..........................................................................................224
5.3.1 Established Companies............................................................................224
5.3.1.1 Boston Scientific Corporation .......................................................................... 224
5.3.1.1.1 Company Overview................................................................................................ 224
5.3.1.1.2 Role of Boston Scientific Corporation in the Gastrointestinal Endoscopy
Market ................................................................................................................... 224
5.3.1.1.3 Financials............................................................................................................... 226
5.3.1.1.4 Recent Developments............................................................................................ 227
5.3.1.1.5 Regional Penetration ............................................................................................. 227
5.3.1.1.6 Analyst Perspectives.............................................................................................. 228
5.3.1.2 Medtronic plc ................................................................................................... 229
5.3.1.2.1 Company Overview................................................................................................ 229
5.3.1.2.2 Role of Medtronic plc in the Gastrointestinal Endoscopy Market .......................... 229
5.3.1.2.3 Financials............................................................................................................... 231
12. 12
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
5.3.1.2.4 Recent Developments............................................................................................ 233
5.3.1.2.5 Regional Penetration ............................................................................................. 233
5.3.1.2.6 Analyst Perspectives.............................................................................................. 233
5.3.1.3 KARL STORZ SE & Co. KG ............................................................................ 235
5.3.1.3.1 Company Overview................................................................................................ 235
5.3.1.3.2 Role of KARL STORZ SE & Co. KG in the Global Gastrointestinal Endoscopy
Market ................................................................................................................... 235
5.3.1.3.3 Recent Developments............................................................................................ 237
5.3.1.3.4 Regional Penetration ............................................................................................. 237
5.3.1.3.5 Analyst Perspectives.............................................................................................. 237
5.3.1.4 Ambu A/S......................................................................................................... 238
5.3.1.4.1 Company Overview................................................................................................ 238
5.3.1.4.2 Role of Ambu A/S in the Global Gastrointestinal Endoscopy Market.................... 238
5.3.1.4.3 Financials............................................................................................................... 239
5.3.1.4.4 Recent Developments............................................................................................ 241
5.3.1.4.5 Regional Penetration ............................................................................................. 241
5.3.1.4.6 Analyst Perspectives.............................................................................................. 241
5.3.1.5 Teleflex Incorporated....................................................................................... 242
5.3.1.5.1 Company Overview................................................................................................ 242
5.3.1.5.2 Role of Teleflex Incorporated in the Gastrointestinal Endoscopy Market.............. 242
5.3.1.5.3 Financials............................................................................................................... 244
5.3.1.5.4 Regional Penetration ............................................................................................. 246
5.3.1.5.5 Analyst Perspectives.............................................................................................. 246
5.3.1.6 HOYA Corporation........................................................................................... 247
5.3.1.6.1 Company Overview................................................................................................ 247
5.3.1.6.2 Role of HOYA Corporation in the Global Gastrointestinal Endoscopy Market ...... 247
5.3.1.6.3 Financials............................................................................................................... 249
5.3.1.6.4 Recent Developments............................................................................................ 250
5.3.1.6.5 Regional Penetration ............................................................................................. 250
5.3.1.6.6 Analyst Perspectives.............................................................................................. 251
13. 13
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
5.3.1.7 Olympus Corporation....................................................................................... 252
5.3.1.7.1 Company Overview................................................................................................ 252
5.3.1.7.2 Role of Olympus Corporation in the Global Gastrointestinal Endoscopy
Market ................................................................................................................... 252
5.3.1.7.3 Financials............................................................................................................... 254
5.3.1.7.4 Recent Developments............................................................................................ 256
5.3.1.7.5 Regional Penetration ............................................................................................. 256
5.3.1.7.6 Analyst Perspectives.............................................................................................. 256
5.3.1.8 FUJIFILM Holdings Corporation ...................................................................... 257
5.3.1.8.1 Company Overview................................................................................................ 257
5.3.1.8.2 Role of FUJIFILM Holdings Corporation in the Global Gastrointestinal
Endoscopy Market ................................................................................................ 257
5.3.1.8.3 Financials............................................................................................................... 259
5.3.1.8.4 Recent Developments............................................................................................ 260
5.3.1.8.5 Regional Penetration ............................................................................................. 260
5.3.1.8.6 Analyst Perspectives.............................................................................................. 261
5.3.1.9 Cook Group Inc................................................................................................ 262
5.3.1.9.1 Company Overview................................................................................................ 262
5.3.1.9.2 Role of Cook Group Inc in the Global Gastrointestinal Endoscopy Market........... 262
5.3.1.9.3 Recent Developments............................................................................................ 263
5.3.1.9.4 Regional Penetration ............................................................................................. 263
5.3.1.9.5 Analyst Perspectives.............................................................................................. 263
5.3.1.10 SonoScape Medical Corp................................................................................ 265
5.3.1.10.1 Company Overview................................................................................................ 265
5.3.1.10.2 Role of SonoScape Medical Corp in the Global Gastrointestinal Endoscopy
Market ................................................................................................................... 265
5.3.1.10.3 Recent Developments............................................................................................ 267
5.3.1.10.4 Regional Penetration ............................................................................................. 267
5.3.1.10.5 Analyst Perspectives.............................................................................................. 267
5.3.2 Start-ups.....................................................................................................268
14. 14
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
5.3.2.1 EndoMed Systems GmbH ............................................................................... 268
5.3.2.1.1 Company Overview................................................................................................ 268
5.3.2.1.2 Role of EndoMed Systems GmbH in the Global Gastrointestinal Endoscopy
Market ................................................................................................................... 268
5.3.2.1.3 Regional Penetration ............................................................................................. 269
5.3.2.1.4 Analyst Perspectives.............................................................................................. 269
5.3.2.2 CapsoVision, Inc.............................................................................................. 270
5.3.2.2.1 Company Overview................................................................................................ 270
5.3.2.2.2 Role of CapsoVision, Inc. in the Gastrointestinal Endoscopy market.................... 270
5.3.2.2.3 Recent Developments............................................................................................ 271
5.3.2.2.4 Regional Penetration ............................................................................................. 271
5.3.2.2.5 Analyst Perspectives.............................................................................................. 271
5.3.2.3 HuiZhou Xzing Technology Co., Ltd................................................................ 272
5.3.2.3.1 Company Overview................................................................................................ 272
5.3.2.3.2 Role of HuiZhou Xzing Technology Co., Ltd. in the Global Gastrointestinal
Endoscopy Market ................................................................................................ 272
5.3.2.3.3 Recent Developments............................................................................................ 273
5.3.2.3.4 Regional Penetration ............................................................................................. 273
5.3.2.3.5 Analyst Perspectives.............................................................................................. 273
5.3.2.4 Endogene Ltd. ................................................................................................. 274
5.3.2.4.1 Company Overview................................................................................................ 274
5.3.2.4.2 Role of Endogene Ltd. in the Gastrointestinal Endoscopy market ........................ 274
5.3.2.4.3 Regional Penetration ............................................................................................. 275
5.3.2.4.4 Analyst Perspectives.............................................................................................. 275
5.3.2.5 Envaste Limited ............................................................................................... 276
5.3.2.5.1 Company Overview................................................................................................ 276
5.3.2.5.2 Role of Envaste Limited in the Global Gastrointestinal Endoscopy Market........... 276
5.3.2.5.3 Regional Penetration ............................................................................................. 277
5.3.2.5.4 Analyst Perspectives.............................................................................................. 277
15. 15
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
List of Figures
Figure 1: Timeline of Endoscopes, 1802-2022
Figure 2: Global Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 3: Global Gastrointestinal Endoscopy Market: Drivers, Restraints, and Opportunities
Figure 4: Global Gastrointestinal Endoscopy Market, Impact Analysis
Figure 5: Global Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 6: Global Gastrointestinal Endoscopy Market (by Region), $Million, 2021 and 2031
Figure 7: Share of Key Developments and Strategies (by Category), January 2018-June 2022
Figure 8: Global Gastrointestinal Endoscopy Market Segmentation
Figure 9: Global Gastrointestinal Endoscopy Market: Research Methodology
Figure 10: Primary Research
Figure 11: Secondary Research
Figure 12: Data Triangulation
Figure 13: Global Gastrointestinal Endoscopy Market Research Process
Figure 14: Assumptions and Limitations
Figure 15: Global Gastrointestinal Endoscopy Market (Realistic Growth Scenario), $Million, 2020-2031
Figure 16: Global Gastrointestinal Endoscopy Market (Optimistic Growth Scenario), $Million, 2020-2031
Figure 17: Global Gastrointestinal Endoscopy Market (Pessimistic Growth Scenario), $Million, 2020-
2031
Figure 18: Global Gastrointestinal Endoscopy Market, Key Trends
Figure 19: Global Gastrointestinal Endoscopy Market Key Trends, Market Shift, 2022-2031
Figure 20: Global Gastrointestinal Endoscopy Market, Product Benchmarking, by Type
Figure 21: Global Gastrointestinal Endoscopy Market, Product Benchmarking, by Endoscopes and
Endoscopic Systems
Figure 22: Global Gastrointestinal Endoscopy Market, Product Benchmarking, by Gastrointestinal
Endotherapy
Figure 23: Various Steps of Reprocessing Endoscope
Figure 24: Number of Positive Cultures after High-Level Disinfection
Figure 25: Global Gastrointestinal Endoscopy Market, Patent Analysis, by Year (January 2019-
December 2021)
Figure 26: Major Gastrointestinal Cancer, Incidence, 2020 vs. 2040
Figure 27: Major Gastrointestinal Cancers, Number of Deaths, 2020 vs. 2040
16. 16
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
Figure 28: Global Gastrointestinal Endoscopy Market (by Type)
Figure 29: Global Gastrointestinal Endoscopy Market Incremental Opportunity (by Type), $Million, 2021-
2031
Figure 30: Global Gastrointestinal Endoscopy Market (by Gastrointestinal Endotherapy), $Million, 2020-
2031
Figure 31: Global Gastrointestinal Endoscopy Market (ERCP Devices), $Million, 2020-2031
Figure 32: Global Gastrointestinal Endoscopy Market (by Gastrointestinal Stents), $Million, 2020-2031
Figure 33: Global Gastrointestinal Endoscopy Market (Esophageal Stents), $Million, 2020-2031
Figure 34: Global Gastrointestinal Endoscopy Market (Biliary Stents), $Million, 2020-2031
Figure 35: Global Gastrointestinal Endoscopy Market (Pancreatic Stents), $Million, 2020-2031
Figure 36: Global Gastrointestinal Endoscopy Market (Balloon Dilators), $Million, 2020-2031
Figure 37: Global Gastrointestinal Endoscopy Market (Ultrasound Endoscopes), $Million, 2020-2031
Figure 38: Global Gastrointestinal Endoscopy Market (Biopsy Devices), $Million, 2020-2031
Figure 39: Global Gastrointestinal Endoscopy Market (Biopsy Forceps), $Million, 2020-2031
Figure 40: Global Gastrointestinal Endoscopy Market (Polypectomy Snares), $Million, 2020-2031
Figure 41: Global Gastrointestinal Endoscopy Market (Other Biopsy Devices), $Million, 2020-2031
Figure 42: Global Gastrointestinal Endoscopy Market (Hemostasis Devices), $Million, 2020-2031
Figure 43: Global Gastrointestinal Endoscopy Market (Retrieval Devices), $Million, 2020-2031
Figure 44: Global Gastrointestinal Endoscopy Market (Others), $Million, 2020-2031
Figure 45: Global Gastrointestinal Endoscopy Market (by Gastrointestinal Endoscopes and Endoscopic
Systems), $Million, 2020-2031
Figure 46: Global Gastrointestinal Endoscopy Market (by Gastrointestinal Videoscopes), $Million, 2020-
2031
Figure 47: Global Gastrointestinal Endoscopy Market (Gastroscopes), $Million, 2020-2031
Figure 48: Global Gastrointestinal Endoscopy Market (Colonoscopes), $Million, 2020-2031
Figure 49: Global Gastrointestinal Endoscopy Market (Duodenoscopes), $Million, 2020-2031
Figure 50: Global Gastrointestinal Endoscopy Market (Sigmoidoscopes), $Million, 2020-2031
Figure 51: Global Gastrointestinal Endoscopy Market (Enteroscopes), $Million, 2020-2031
Figure 52: Global Gastrointestinal Endoscopy Market (Anoscopes), $Million, 2020-2031
Figure 53: Global Gastrointestinal Endoscopy Market (Visualization Systems), $Million, 2020-2031
Figure 54: Global Gastrointestinal Endoscopy Market (Capsule Endoscopes), $Million, 2020-2031
Figure 55: Global Gastrointestinal Endoscopy Market (by End User)
17. 17
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
Figure 56: Global Gastrointestinal Endoscopy Market Incremental Opportunity (by End User), $Million,
2021-2031
Figure 57: Global Gastrointestinal Endoscopy Market (Hospitals), $Million, 2020-2031
Figure 58: Global Gastrointestinal Endoscopy Market (Ambulatory Surgery Centers), $Million, 2020-
2031
Figure 59: Global Gastrointestinal Endoscopy Market (Others), $Million, 2020-2031
Figure 60: Global Gastrointestinal Endoscopy Market, Share (by Region), 2021 and 2031
Figure 61: North America Gastrointestinal Endoscopy Market Incremental Revenue Opportunity (by
Country), $Million, 2021-2031
Figure 62: Incidence of Gastrointestinal Cancer, North America, 2020 vs. 2040
Figure 63: North America Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 64: North America Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 65: North America Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 66: North America Gastrointestinal Endoscopy Market (by Gastrointestinal Endoscopes and
Endoscopic Systems), $Million, 2020-2031
Figure 67: North America Gastrointestinal Endoscopy Market (by Gastrointestinal Videoscopes),
$Million, 2020-2031
Figure 68: North America Gastrointestinal Endoscopy Market (by Gastrointestinal Endotherapy),
$Million, 2020-2031
Figure 69: North America Gastrointestinal Endoscopy Market (by Gastrointestinal Stents), $Million,
2020-2031
Figure 70: North America Gastrointestinal Endoscopy Market (by Biopsy Devices), $Million, 2020-2031
Figure 71: U.S. Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 72: U.S. Gastrointestinal Endoscopy Market (by End User), $Million 2020-2031
Figure 73: U.S. Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 74: Incidence of New Colorectal Cancer Cases and Other Cancers, Canada, 2022
Figure 75: Deaths Caused due to Colorectal Cancer and Other Cancers, Canada, 2022
Figure 76: Canada Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 77: Canada Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 78: Canada Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 79: Europe Gastrointestinal Endoscopy Market Incremental Revenue Opportunity (by Country),
$Million, 2021-2030
Figure 80: Incidence of Gastrointestinal Cancer, Europe, 2020 vs. 2040
18. 18
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
Figure 81: Incidence of Gastrointestinal Cancer, Northern Europe, Southern Europe, Eastern Europe,
and Western Europe, 2020 vs. 2040
Figure 82: Europe Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 83: Europe Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 84: Europe Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 85: Europe Gastrointestinal Endoscopy Market (by Gastrointestinal Endoscopes and Endoscopic
Systems), $Million, 2020-2031
Figure 86: Europe Gastrointestinal Endoscopy Market (by Gastrointestinal Videoscopes), $Million,
2020-2031
Figure 87: Europe Gastrointestinal Endoscopy Market (by Gastrointestinal Endotherapy), $Million, 2020-
2031
Figure 88: Europe Gastrointestinal Endoscopy Market (by Gastrointestinal Stents), $Million, 2020-2031
Figure 89: Europe Gastrointestinal Endoscopy Market (by Biopsy Devices), $Million, 2020-2031
Figure 90: Germany Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 91: Germany Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 92: Germany Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 93: U.K. Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 94: U.K. Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 95: U.K. Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 96: Incidence of Gastrointestinal Cancer, France, 2020 vs. 2040
Figure 97: France Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 98: France Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 99: France Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 100: Incidence of Gastrointestinal Cancer, Italy, 2020 vs. 2040
Figure 101: Italy Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 102: Italy Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 103: Italy Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 104: Incidence of Gastrointestinal Cancer, Spain, 2020 vs. 2040
Figure 105: Spain Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 106: Spain Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 107: Spain Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 108: Rest-of-Europe Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 109: Rest-of-Europe Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
19. 19
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
Figure 110: Rest-of-Europe Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 111: Asia-Pacific Gastrointestinal Endoscopy Market Incremental Revenue Opportunity (by
Country), $Million, 2021-2031
Figure 112: Incidence of Gastrointestinal Cancer, Asia-Pacific, 2020 vs. 2040
Figure 113: Asia-Pacific Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 114: Asia-Pacific Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 115: Asia-Pacific Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 116: Asia-Pacific Gastrointestinal Endoscopy Market (by Gastrointestinal Endoscopes and
Endoscopic Systems), $Million, 2020-2031
Figure 117: Asia-Pacific Gastrointestinal Endoscopy Market (by Gastrointestinal Videoscopes), $Million,
2020-2031
Figure 118: Asia-Pacific Gastrointestinal Endoscopy Market (by Gastrointestinal Endotherapy), $Million,
2020-2031
Figure 119: Asia-Pacific Gastrointestinal Endoscopy Market (by Gastrointestinal Stents), $Million, 2020-
2031
Figure 120: Asia-Pacific Gastrointestinal Endoscopy Market (by Biopsy Devices), $Million, 2020-2031
Figure 121: Japan Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 122: Japan Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 123: Japan Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 124: Incidence of Gastrointestinal Cancer, China, 2020 vs. 2040
Figure 125: China Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 126: China Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 127: China Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 128: Incidence of Gastrointestinal Cancer, South Korea, 2020 vs. 2040
Figure 129: South Korea Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 130: South Korea Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 131: South Korea Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 132: Incidence of Gastrointestinal Cancer, India, 2020 vs. 2040
Figure 133: India Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 134: India Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 135: India Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 136: Incidence of Gastrointestinal Cancer, Australia and New Zealand, 2020 vs. 2040
Figure 137: Australia and New Zealand Gastrointestinal Endoscopy Market, $Million, 2020-2031
20. 20
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
Figure 138: Australia and New Zealand Gastrointestinal Endoscopy Market (by End User), $Million,
2020-2031
Figure 139: Australia and New Zealand Gastrointestinal Endoscopy Market (by Type), $Million, 2020-
2031
Figure 140: Rest-of-Asia-Pacific Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 141: Rest-of-Asia-Pacific Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 142: Rest-of-Asia-Pacific Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 143: Latin America Gastrointestinal Endoscopy Market Incremental Revenue Opportunity (by
Country), $Million, 2021-2031
Figure 144: Incidence of Gastrointestinal Cancer, Latin America and the Caribbean Region, 2020 vs.
2040
Figure 145: Latin America Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 146: Latin America Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 147: Latin America Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 148: Latin America Gastrointestinal Endoscopy Market (by Gastrointestinal Endoscopes and
Endoscopic Systems), $Million, 2020-2031
Figure 149: Latin America Gastrointestinal Endoscopy Market (by Gastrointestinal Videoscopes),
$Million, 2020-2031
Figure 150: Latin America Gastrointestinal Endoscopy Market (by Gastrointestinal Endotherapy),
$Million, 2020-2031
Figure 151: Latin America Gastrointestinal Endoscopy Market (by Gastrointestinal Stents), $Million,
2020-2031
Figure 152: Latin America Gastrointestinal Endoscopy Market (by Biopsy Devices), $Million, 2020-2031
Figure 153: Incidence of Gastrointestinal Cancer, Mexico, 2020 vs. 2040
Figure 154: Mexico Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 155: Mexico Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 156: Mexico Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 157: Brazil Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 158: Brazil Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 159: Brazil Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 160: Argentina Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 161: Argentina Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 162: Argentina Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 163: Rest-of-Latin America Gastrointestinal Endoscopy Market, $Million, 2020-2031
21. 21
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
Figure 164: Rest-of-Latin America Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 165: Rest-of-Latin America Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 166: Middle East and Africa Gastrointestinal Endoscopy Market Incremental Revenue Opportunity
(by Country), $Million, 2021-2031
Figure 167: Middle East and Africa Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 168: Middle East and Africa Gastrointestinal Endoscopy Market (by End User), $Million, 2020-
2031
Figure 169: Middle East and Africa Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 170: Middle East and Africa Endoscopy Market (by Gastrointestinal Endoscopes and Endoscopic
Systems), $Million, 2020-2031
Figure 171: Middle East and Africa a Gastrointestinal Endoscopy Market (by Gastrointestinal
Videoscopes), $Million, 2020-2031
Figure 172: Middle East and Africa Gastrointestinal Endoscopy Market (by Gastrointestinal Endotherapy),
$Million, 2020-2031
Figure 173: Middle East and Africa Gastrointestinal Endoscopy Market (by Gastrointestinal Stents),
$Million, 2020-2031
Figure 174: Middle East and Africa Gastrointestinal Endoscopy Market (by Biopsy Devices), $Million,
2020-2031
Figure 175: Incidence of Gastrointestinal Cancer, K.S.A, 2020 vs. 2040
Figure 176: K.S.A. Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 177: K.S.A. Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 178: K.S.A. Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 179: Incidence of Gastrointestinal Cancer, U.A.E., 2020 vs. 2040
Figure 180: U.A.E. Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 181: U.A.E. Gastrointestinal Endoscopy Market (by End User), $Million, 2020-2031
Figure 182: U.A.E. Gastrointestinal Endoscopy Market (by Type), $Million, 2020-2031
Figure 183: Incidence of Gastrointestinal Cancer, Rest-of-Middle East and Africa, 2020 vs. 2040
Figure 184: Rest-of-Middle East and Africa Gastrointestinal Endoscopy Market, $Million, 2020-2031
Figure 185: Rest-of-Middle East and Africa Gastrointestinal Endoscopy Market (by End User), $Million,
2020-2031
Figure 186: Rest-of-Middle East and Africa Gastrointestinal Endoscopy Market (by Type), $Million, 2020-
2031
Figure 187: Share of Key Developments and Strategies, January 2018-June 2022
Figure 188: Regulatory and Legal Share (by Company), January 2018-June 2022
22. 22
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
Figure 189: Funding Activities Share (by Company), January 2018-June 2022
Figure 190: New Offerings Share (by Company), January 2018-June 2022
Figure 191: Mergers and Acquisitions Share (by Company), January 2018-June 2022
Figure 192: Partnerships, Collaborations, and Business Expansions Share (by Company), January 2018-
June 2022
Figure 193: Global Gastrointestinal Endoscopy Market, Share Analysis (by Company), 2021
Figure 194: Boston Scientific Corporation: Product Portfolio
Figure 195: Boston Scientific Corporation: Overall Financials 2019-2021
Figure 196: Boston Scientific Corporation: Net Revenue (by Segment), $Million, 2019-2021
Figure 197: Boston Scientific Corporation: R&D Expenditure, $Million, 2019-2021
Figure 198: Medtronic plc: Product Portfolio
Figure 199: Medtronic plc: Overall Financials 2020-2022
Figure 200: Medtronic plc: Net Revenue (by Segment), $Million, 2020-2022
Figure 201: Medtronic plc: Net Revenue (by Region), $Million, 2020-2022
Figure 202: Medtronic plc: R&D Expenditure, $Million, 2020-2022
Figure 203: KARL STORZ SE & Co. KG: Product Offerings
Figure 204: Ambu A/S: Product Portfolio
Figure 205: Ambu A/S: Overall Financials, $Million, 2019-2021
Figure 206: Ambu A/S: Net Revenue (by Segment), $Million, 2019-2021
Figure 207: Ambu A/S: Net Revenue (by Region), $Million, 2019-2021
Figure 208: Teleflex Incorporated: Product Portfolio
Figure 209: Teleflex Incorporated: Overall Financials, 2019-2021
Figure 210: Teleflex Incoporated: Net Revenue (by Segment), $Million, 2019-2021
Figure 211: Teleflex Incorporated: Net Revenue (by Region), $Million, 2019-2021
Figure 212: Teleflex Incorporated: R&D Expenditure, $Million, 2019-2021
Figure 213: HOYA Corporation: Product Portfolio
Figure 214: HOYA Corporation: Overall Financials, $Million, 2019-2021
Figure 215: HOYA Corporation: R&D Expenditure, $Million, 2019-2020
Figure 216: Olympus Corporation: Product Portfolio
Figure 217: Olympus Corporation: Overall Financials, $Million, 2019-2021
Figure 218: Olympus Corporation: Net Revenue (by Segment), $Million, 2020-2021
Figure 219: Olympus Corporation: R&D Expenditure, $Million, 2019-2021
Figure 220: FUJIFILM Holdings Corporation: Product Portfolio
23. 23
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
Figure 221: FUJIFILM Holdings Corporation: Overall Financials, $Million, 2018-2020
Figure 222: FUJIFILM Holdings Corporation: Net Revenue (by Segment), $Million, 2018-2020
Figure 223: FUJIFILM Holdings Corporation: R&D Expenditure, $Million, 2018-2020
Figure 224: Cook Group Inc: Product Portfolio
Figure 225: SonoScape Medical Corp: Product Offerings
Figure 226: EndoMed Systems GmbH: Product Portfolio
Figure 227: CapsoVision, Inc.: Product Portfolio
Figure 228: HuiZhou Xzing Technology Co., Ltd.: Product Offerings
Figure 229: Endogene Ltd.: Product Portfolio
Figure 230: Envaste Limited: Product Portfolio
24. 24
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
List of Tables
Table 1: Global Gastrointestinal Endoscopy Market, Key Developments and Strategies Analysis (by
Company and Year), January 2018-June 2022
Table 2: Key Questioned Answered in the Report
Table 3: Comparative Analysis of Conventional Surgery and Robot-Assisted Surgery
Table 4: Robotics and Artificial Intelligence, Gastrointestinal Endoscopy
Table 5: Conventional Surgery vs. Robot-Assisted Surgery, Cost Analysis
Table 6: Robot-Assisted Surgery and Conventional Surgery, Comparative Analysis, Length of Stay (in
Days)
Table 7: Comparative analysis of Disposable Endoscope vs. Reusable Endoscope
Table 8: Some of the Ongoing Clinical Trials in Global Gastrointestinal Endoscopy Market
Table 9: Global Gastrointestinal Endoscopy Market, COVID-19 Regional Impact
Table 10: Gastrointestinal Endoscopy Market Dynamics, Impact Analysis
Table 11: Comparative Analysis of Open Surgery vs. Minimally Invasive Surgery, Total Average
Residency Case Volumes, 2003-2019, U.S.
Table 12: Reimbursement Framework, Surgical Procedures vs. Endoscopic Procedures, 2020
Table 13: Some of the Major Companies of Biliary Stents
Table 14: North America Gastrointestinal Endoscopy Market, Regulatory Framework
Table 15: North America Gastrointestinal Endoscopy Market Dynamics, Impact Analysis
Table 16: Europe Gastrointestinal Endoscopy Market, Regulatory Framework
Table 17: Europe Gastrointestinal Endoscopy Market Dynamics, Impact Analysis
Table 18: Asia-Pacific Gastrointestinal Endoscopy Market, Regulatory Framework
Table 19: Asia-Pacific Gastrointestinal Endoscopy Market Dynamics, Impact Analysis
Table 20: Latin America Gastrointestinal Endoscopy Market, Regulatory Framework
Table 21: Latin America Gastrointestinal Endoscopy Market Dynamics, Impact Analysis
Table 22: Middle East and Africa Gastrointestinal Endoscopy Market, Regulatory Framework
Table 23: Middle East and Africa Gastrointestinal Endoscopy Market Dynamics, Impact Analysis
Table 24: Some of the Gastrointestinal Endoscopy Product Offered by Boston Scientific Corporation
Table 25: Some of the Gastrointestinal Endoscopy Products Offered by Medtronic plc
Table 26: Some of the Gastrointestinal Endoscopy Product Offered by KARL STROZ SE & Co. KG
Table 27: Some of the Gastrointestinal Endoscopy Product Offered by Ambu A/S
Table 28: Some of the Gastrointestinal Endoscopy Product Offered by Teleflex Incorporated
25. 25
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
Table 29: Some of the Gastrointestinal Endoscopy Product Offered by HOYA Corporation
Table 30: Some of the Gastrointestinal Endoscopy Product Offered by Olympus Corporation
Table 31: Some of the Gastrointestinal Endoscopy Product Offered by FUJIFILM Holdings Corporation
Table 32: Some of the Gastrointestinal Endoscopy Product Offered by Cook Group Inc.
Table 33: Some of the Gastrointestinal Endoscopy Product Offered by SonoScape Medical Corp
Table 34: Some of the Gastrointestinal Endoscopy Product Offered by EndoMed Systems GmbH
Table 35: Some of the Gastrointestinal Endoscopy Product Offered by CapsoVision, Inc.
Table 36: Some of the Gastrointestinal Endoscopy Product Offered by HuiZhou Xzing Technology Co.,
Ltd.
Table 37: Some of the Gastrointestinal Endoscopy Product Offered by Endogene Ltd.
Table 38: Some of the Gastrointestinal Endoscopy Product Offered by Envaste Limited
26. 26
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
BIS Research Offerings:
We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s
digital age. We have a vision to be a leading and a preferred knowledge partner for corporates and institutions
worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other
innovative solutions.
Know More
Know More
Know More
Know More
27. 27
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
Disclaimer
BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to
orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth.
This document and its contents are confidential and may not be further distributed, published, or reproduced,
in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS
Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly
through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information
to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce
Information in legal proceedings.
Market reports are based on expectations, estimates, and projections as of the date such information is
available. Any recommendation contained in this report may not be suitable for all investors or businesses.
The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while
considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to
market fluctuations and business, economic and competitive uncertainties and contingencies.
For more details regarding permission, please contact us:
Email: sales@bisresearch.com
Tel: +1 510 404 8135
28. 28
All rights reserved at BIS Research Inc.
G
A
S
T
R
O
I
N
T
E
S
T
I
N
A
L
E
N
D
O
S
C
O
P
Y
M
A
R
K
E
T
BIS RESEARCH INC.
39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686
E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135
Global Delivery Center
Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway,
Sector 126, Noida, U.P., 201303, India
Tel: +91 120 4261540 / 4261544
www.bisresearch.com